View Older Stories View More Recent Stories
-
POZEN and Tribute Announce Plan to Proceed With Merger to Form Aralez Pharmaceuticals
-
Cardica Issues Statement Regarding Its Upcoming Annual Meeting of Stockholders
-
Cardica and Broadfin Capital Announce Framework of a Settlement Agreement
-
Form 13F-HR Broadfin Capital, LLC For: Sep 30
-
Form SC 13G/A Aegerion Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Recro Pharma Reports Third Quarter 2015 Financial Results
-
Cynapsus Therapeutics Reports Third Quarter 2015 Financial Results and Recent Developments
-
RedHill Biopharma Reports Results for the Third Quarter of 2015
-
Form SC 13G ARATANA THERAPEUTICS, Filed by: Broadfin Capital, LLC
-
Form SC 13G NOVADAQ TECHNOLOGIES Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes Third Quarter 2015 PIPE Market League Tables
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
-
Form SC 13G NEVRO CORP Filed by: Broadfin Capital, LLC
-
Form SC 13D/A CARDICA INC Filed by: Broadfin Capital, LLC
-
Broadfin Capital Sends Open Letter to Cardica (CRDC)
-
Broadfin Issues Open Letter To Cardica's Shareholders
-
Form SC 13G ANTARES PHARMA, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13D CARDICA INC Filed by: Broadfin Capital, LLC
-
Form SC 13D/A MELA SCIENCES, INC. /NY Filed by: Broadfin Capital, LLC
-
Recro Pharma Reports Second Quarter 2015 Financial Results
-
Cynapsus Therapeutics Reports Second Quarter 2015 Financial Results and Recent Developments
-
Form 13F-HR Broadfin Capital, LLC For: Jun 30
-
ContraFect Corporation Announces Second Quarter 2015 Financial and Operating Results
-
Form SC 13G Advaxis, Inc. Filed by: Broadfin Capital, LLC
-
RedHill Biopharma Reports Results for the Second Quarter of 2015
-
The PIPEs Report Sees Small-Cap Equity, Financing Capital And Volume Rise For Q2 2015 -- Busiest May For PIPEs In Seven Years
-
RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
-
Form SC 13G SeaSpine Holdings Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G MEDGENICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13D Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes First Half 2015 PIPE Market League Tables
-
Recro Pharma Completes $16 Million Private Financing
-
Cortendo AB: Cortendo Provides 2015 Half-Year Update on Corporate Progress
-
Form SC 13G RITTER PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G QLT INC/BC Filed by: Broadfin Capital, LLC
-
Form SC 13G CONTRAFECT Corp Filed by: Broadfin Capital, LLC
-
ContraFect Corporation Announces $20,000,000 Private Placement
-
QLT, Inc. (QLTI) to Buy Insite Vision, Make Investment in Araleza
-
QLT Announces Multiple Transactions Designed to Transform the Company and Create Significant Near- and Long-Term Value for Shareholders
-
Ardelyx (ARDX) Announces $77.8M Common Stock, Warrants Offering
-
Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015
-
Broadfin Capital Shows New 5.6% Stake in SCYNEXIS (SCYX)
-
Form SC 13G SCYNEXIS INC Filed by: Broadfin Capital, LLC
-
Broadfin Capital Raises Stake in BioDelivery Sciences (BDSI) to 7.3%
-
Form SC 13G BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Mar 31
-
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
-
Cynapsus Therapeutics Inc. : Reports First Quarter 2015 Financial Results and Recent Developments
-
RedHill Biopharma Reports Results for the First Quarter of 2015
-
Form SC 13G KEMPHARM, INC Filed by: Broadfin Capital, LLC

